Skip NavigationSkip to Content

2'-Fluoro-2',3'-Dideoxyarabinosyladenine (F-Dda) - Activity Against Drug-Resistant Human Immunodeficiency Virus Strains and Clades a-E

  1. Author:
    Driscoll, J. S.
    Mayers, D. L.
    Bader, J. P.
    Weislow, O. S.
    Johns, D. G.
    Buckheit, R. W.
  2. Author Address

    Driscoll JS NCI MED CHEM LAB DIV BASIC SCI NIH BLDG 37 ROOM 5C-02 BETHESDA, MD 20892 USA WALTER REED ARMY INST RES ROCKVILLE, MD 20850 USA NCI ANTIVIRAL EVALUAT BRANCH ROCKVILLE, MD 20852 USA SRA TECHNOL ROCKVILLE, MD 20850 USA FREDERICK CANC RES & DEV CTR SO RES INST VIROL RES GRP FREDERICK, MD 21701 USA
    1. Year: 1997
  1. Journal: Antiviral Chemistry & Chemotherapy
    1. 8
    2. 2
    3. Pages: 107-111
  2. Type of Article: Article
  1. Abstract:

    2'-Fluoro-2',3'-dideoxyarabinosyladenine (F-ddA), an anti-human immunodeficiency virus (HIV) drug currently in clinical trial, was compared with zidovudine (ATT), ddl and ddC for anti-HIV activity and potency in HIV-1 strains both sensitive and resistant to zidovudine, ddl and non-nucleoside reverse transcriptase inhibitors. A variety of host cell systems [MT-2, MT-4, phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMC)] was used. F-ddA was effective against each of the drug-resistant isolates, including the strain resistant to ddl, the other purine dideoxynucleoside evaluated in this study. The anti-HIV-1 activities of F-ddA and zidovudine were also determined against clades A-E in PHA-PBMCs. Although activities were similar, zidovudine was significantly more potent than F-ddA in the PHA-PBMC system. [References: 28]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel